Published: 2015-02-25

Proceedings

The Evolving Landscape of GI Tumors

Francesco Di Costanzo
Abstract 32 | PDF Downloads 4

Page 3

HER-2 and Gastric Cancer

Francesco Graziano
Abstract 31 | PDF Downloads 5

Page 5-7

MicroRNA

Annarosa Arcangeli, Gianluca Bartoli, Elisa Giommoni
Abstract 35 | PDF Downloads 3

Page 8-10

Circulating tumor cells: current challenges and future perspectives

Marco Danova, Martina Torchio, Giuditta Comolli, Valerio Gristina, Giuliano Mazzini
Abstract 36 | PDF Downloads 6

Page 11-13

Update in localized rectal cancer

Carlo Aschele, Amalia Milano
Abstract 36 | PDF Downloads 7

Page 14-17

Therapeutic algorithm of pancreatic neuroendocrine neoplasms

Nicola Fazio, Lorenzo Antonuzzo
Abstract 21 | PDF (Italiano) Downloads 8

Page 18-20

Neoadjuvant therapy of gastroesophageal junction adenocarcinoma: chemoradiotherapy or chemotherapy

Antonino De Paoli, Maria Di Bartolomeo
Abstract 30 | PDF Downloads 8

Page 21-23

Gastric Cancer: therapeutic choices in advanced disease

Mario Scartozzi, Alessandro Bittoni, Riccardo Giampieri, Luca Faloppi, Michela Del Prete, Maristella Bianconi, Agnese Fulli, Stefano Cascinu
Abstract 36 | PDF Downloads 7

Page 24-25

S-1 in the treatment of advanced gastric cancer: up-date

Rosa Laface, Elisa Giommoni, Francesco Di Costanzo
Abstract 39 | PDF Downloads 5

Page 26-29

Ramucirumab: a new option in advanced gastric cancer

Ferdinando De Vita, Jole Ventriglia, Marilena Laterza, Alessio Fabozzi, Fortunato Ciardiello, Michele Orditura
Abstract 36 | PDF Downloads 6

Page 30-32

Bevacizumab beyond progression: Pros

Gianluca Masi
Abstract 59 | PDF Downloads 3

Page 33-35

The Challenge of anti-EGFR therapy-rechallenge in management of metastatic colorectal cancer

Daniele Santini, Marco Imperatori, Bruno Vincenzi, Giuseppe Tonini
Abstract 94 | PDF Downloads 9

Page 36-39

Second line treatment of metastatic colorectal cancer: aflibercept

Carmelo Pozzo, Ernesto Rossi
Abstract 16 |

Page 40-44

Resistance to biologic drugs

Marzia Del Re, Romano Danesi
Abstract 16 | PDF Downloads 8

Page 45-46

Monotherapy vs doublet chemotherapy vs Folfirinox: who and why

Evaristo Maiello, Paolo Petreni, Elisa Giommoni, Luciano Nanni, Tiziana Pia Latiano, Francesco Di Costanzo
Abstract 19 | PDF Downloads 6

Page 47-49

SPARC and treatment in pancreatic ductal adenocarcinoma: evidences and new challenge for the future

Elisa Giommoni, Rosa Laface, Elena Molinara, Francesco Di Costanzo
Abstract 16 | PDF Downloads 8

Page 50-51

Update on nab-Paclitaxel in the treatment of pancreatic cancer

Michele Milella, Vanja Vaccaro
Abstract 19 | PDF Downloads 4

Page 52-54